This study examines the relationship between testosterone therapy and cancer risk, particularly its impact on prostate cancer. The findings suggest that testosterone therapy does not increase the risk of prostate cancer recurrence, even in men with high-risk prostate cancer. However, due to the retrospective nature of this and prior studies,
